Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-28 Sale |
2024-02-29 6:50 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
140 | $88.46 | $12,384 | 71,225 (Direct) |
View |
| 2023-09-22 Purchase |
2023-09-25 4:44 pm |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
4,000 | $59.38 | $237,529 | 73,090 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 5:18 pm |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
4,444 | $77.2 | $343,081 | 38,488 (Direct) |
View |
| 2023-05-10 Sale |
2023-05-12 3:43 pm |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,408 | $77.13 | $494,225 | 26,711 (Direct) |
View |
| 2023-05-08 Sale |
2023-05-10 7:15 pm |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,408 | $76.56 | $490,628 | 42,213 (Direct) |
View |
| 2023-03-24 Sale |
2023-03-28 5:00 pm |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
300 | $69.92 | $20,977 | 16,308 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-27 Option Award |
2024-02-29 6:50 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
36,480 | $0 | 51,477 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:50 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
72,960 | $0 | 162,405 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
799 | $55.75 | 71,225 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:50 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
36,480 | $0 | 71,225 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
140 | $57.22 | 71,225 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
325 | $58.49 | 71,225 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 6:50 pm |
N/A 2030-02-13 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,264 | $0 | 71,225 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:49 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
164,159 | $0 | 235,868 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
593 | $74.65 | 14,997 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
4,778 | $74.65 | 89,445 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,479 | $74.65 | 21,423 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
1,381 | $74.65 | 71,709 (Direct) |
View |
| 2023-12-29 Other |
2024-01-04 4:07 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
179 | $60.71 | 15,769 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-04 4:07 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
2,917 | $72.31 | 94,223 (Direct) |
View |
| 2023-12-05 Tax Withholding |
2023-12-06 3:27 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,269 | $59.61 | 22,902 (Direct) |
View |
| 2023-12-05 Tax Withholding |
2023-12-06 3:27 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
1,984 | $59.61 | 97,140 (Direct) |
View |
| 2023-10-01 Tax Withholding |
2023-10-03 4:36 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
346 | $59.92 | 24,171 (Direct) |
View |
| 2023-09-22 Option Award |
2023-09-26 4:41 pm |
N/A 2033-09-22 |
LIGAND PHARMACEUTICALS INC | LGND | Zimmermann Martine Director |
13,630 | $0 | 13,630 (Direct) |
View |
| 2023-08-10 Tax Withholding |
2023-08-14 4:20 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & |
897 | $68.73 | 15,411 (Direct) |
View |
| 2023-06-30 Other |
2023-07-10 6:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
376 | $56.78 | 99,500 (Direct) |
View |
| 2023-06-30 Other |
2023-07-10 6:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
375 | $56.78 | 24,892 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-21 09:28 am |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,603 | $0 | 32,387 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:55 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
6,603 | $0 | 12,028 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:55 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
6,603 | $0 | 33,724 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:54 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,603 | $0 | 45,091 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:54 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
6,603 | $0 | 133,609 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:53 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director |
6,603 | $0 | 9,606 (Direct) |
View |
| 2023-06-09 Tax Withholding |
2023-06-13 6:52 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
420 | $73.76 | 69,090 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-12 3:43 pm |
N/A 2023-06-11 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,408 | $0 | 26,711 (Direct) |
View |
| 2023-05-08 Exercise |
2023-05-10 7:15 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,408 | $18.82 | 42,213 (Direct) |
View |
| 2023-05-08 Exercise |
2023-05-10 7:15 pm |
N/A 2023-06-11 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,408 | $0 | 42,213 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:54 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
22,465 | $0 | 40,561 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:52 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
33,697 | $0 | 123,376 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:51 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
21,061 | $0 | 32,001 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:50 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
63,183 | $0 | 114,969 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 7:23 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
2,890 | $72.98 | 89,679 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 7:20 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
849 | $72.98 | 18,096 (Direct) |
View |
| 2022-12-30 Other |
2023-01-04 5:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
275 | $56.78 | 19,220 (Direct) |
View |
| 2022-12-28 Tax Withholding |
2022-12-30 5:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
3,859 | $66.29 | 92,569 (Direct) |
View |
| 2022-12-28 Tax Withholding |
2022-12-30 5:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
5,289 | $66.29 | 417,695 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:37 pm |
N/A 2024-12-05 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
92,932 | $0 | 92,932 (Direct) |
View |